Rosemont Pharmaceuticals
Gerard Murphy is an experienced Project Manager and QC Validation Analyst at Rosemont Pharmaceuticals, specializing in cleaning validation within cGMP and GLP environments under regulatory frameworks including MHRA, EMA, and FDA since April 2021. As a Second Lieutenant and Officer Cadet in the British Army, Gerard is affiliated with the Leeds University Officer Training Corps and has completed the Royal Military Academy Sandhurst Reserve Commissioning Course. Gerard's background includes significant roles in student engagement and support at the University of Leeds, where responsibilities involved public speaking, workshop facilitation, and promoting access to higher education. Additional experience encompasses project management at Dstl and quality control at various laboratories, along with a solid educational foundation in Biology from the University of Leeds.
Rosemont Pharmaceuticals
At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.